Electrolytes assessed by point-of-care testing - Are the values comparable with results obtained from the central laboratory?
Chacko B, Peter JV, Patole S, Fleming JJ, Selvakumar R
Purpose
Conclusion
Studies (1)
Purpose
The purpose of this study was to determine the effects of analyzing whole blood at the bedside rather than analyzing serum after sending whole blood through a PTS on sodium and potassium levels. Specimens for analysis at the bedside were collected into an ABG syringe coated with lithium heparin, while specimens for analysis in the central lab were collected in BD vacutainers for serum.
Summary of Findings
After PTS transport, serum sodium levels, measured in the central lab using the AU2700, were an average of 4 mmol/L higher than whole blood levels measured using a GEM 3000 at the patient bedside (p<0.001). Generally, potassium levels in PTS transported serum and untransported whole blood showed good agreement (Lin concordance correlation, Pc0.96), but when potassium levels were below 3 mmol/L, the serum levels were, on average, 0.6 mmol/L higher in transported specimens, and the agreement between the two was low (Pc=0.53). The differences in levels of potassium (below 3 mmol/L only) or sodium between whole blood analyzed at the bedside and serum analyzed after PTS transport were clinically relevant.
Biospecimens
FluidBloodFluidSerumPreservation Types
None (Fresh)Diagnoses
Not specifiedPlatforms
Electrolyte/MetalClinical chemistry/auto analyzerPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Aliquots and Components Blood and blood products SerumWhole bloodStorage Within hospital transportation method Not transportedPneumatic tube systemClinical chemistry/auto analyzer Specific Technology platform AU2700 (indirect ion selective electrode)GEM 3000 (direct ion selective electrode)